Last reviewed · How we verify
PRO-148
PRO-148 is an ophthalmic anti-inflammatory agent designed to reduce ocular surface inflammation and associated symptoms.
PRO-148 is an ophthalmic anti-inflammatory agent designed to reduce ocular surface inflammation and associated symptoms. Used for Dry eye disease.
At a glance
| Generic name | PRO-148 |
|---|---|
| Also known as | PRO-148 (xanthan gum and sulphate chondroitin) |
| Sponsor | Laboratorios Sophia S.A de C.V. |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
PRO-148 is developed by Laboratorios Sophia for treatment of dry eye disease and related ocular surface conditions. The drug targets inflammatory pathways involved in ocular surface disease, though the precise molecular mechanism has not been widely disclosed in public literature.
Approved indications
- Dry eye disease
Common side effects
Key clinical trials
- Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome (PHASE2)
- Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |